144 related articles for article (PubMed ID: 38086239)
1. Discovery of highly efficient CRBN-recruiting HPK1-PROTAC as a potential chemical tool for investigation of scaffolding roles in TCR signaling.
Zeng S; Jin Y; Xia H; Shang Y; Li Y; Wang Z; Huang W
Bioorg Chem; 2024 Feb; 143():107016. PubMed ID: 38086239
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 7H-Pyrrolo[2,3-d]pyrimidine Derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.
Wu F; Li H; An Q; Sun Y; Yu J; Cao W; Sun P; Diao X; Meng L; Xu S
Eur J Med Chem; 2023 Jun; 254():115355. PubMed ID: 37062169
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 1H-pyrazolo[3,4-d]pyrimidine derivatives as hematopoietic progenitor kinase 1 (HPK1) inhibitors.
Zhang J; Li Y; Tang H; Zhou Q; Tong L; Ding J; Xie H; Xiong B; Liu T
Bioorg Chem; 2023 Nov; 140():106811. PubMed ID: 37659145
[TBL] [Abstract][Full Text] [Related]
4. Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling.
Ling P; Meyer CF; Redmond LP; Shui JW; Davis B; Rich RR; Hu MC; Wange RL; Tan TH
J Biol Chem; 2001 Jun; 276(22):18908-14. PubMed ID: 11279207
[TBL] [Abstract][Full Text] [Related]
5. Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1.
Zhou L; Ye X; Wang K; Shen H; Wang T; Zhang X; Jiang S; Xiao Y; Zhang K
Bioorg Chem; 2023 Sep; 138():106682. PubMed ID: 37339563
[TBL] [Abstract][Full Text] [Related]
6. Discovery of LHF418 as a new potent SOS1 PROTAC degrader.
Li H; Chai M; Chen Y; Zhou F; Ren X; Xu J; Wang J; Wang Z; Huang W
Bioorg Med Chem; 2024 Apr; 103():117661. PubMed ID: 38489998
[TBL] [Abstract][Full Text] [Related]
7. The adaptor protein Gads (Grb2-related adaptor downstream of Shc) is implicated in coupling hemopoietic progenitor kinase-1 to the activated TCR.
Liu SK; Smith CA; Arnold R; Kiefer F; McGlade CJ
J Immunol; 2000 Aug; 165(3):1417-26. PubMed ID: 10903746
[TBL] [Abstract][Full Text] [Related]
8. Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders.
Yang X; Wang Z; Pei Y; Song N; Xu L; Feng B; Wang H; Luo X; Hu X; Qiu X; Feng H; Yang Y; Zhou Y; Li J; Zhou B
Eur J Med Chem; 2021 Jun; 218():113341. PubMed ID: 33780898
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Pharmacological Evaluation of Isoindoline Analogues as New HPK1 Inhibitors.
Xie C; Liu B; Song Z; Yang Y; Dai M; Gao Y; Yao Y; Ding C; Ai J; Zhang A
J Med Chem; 2023 Dec; 66(23):16201-16221. PubMed ID: 37990878
[TBL] [Abstract][Full Text] [Related]
10. Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death.
Brenner D; Golks A; Kiefer F; Krammer PH; Arnold R
EMBO J; 2005 Dec; 24(24):4279-90. PubMed ID: 16341093
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 5-aminopyrido[2,3-d]pyrimidin-7(8H)-one derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors.
Qiu X; Liu R; Ling H; Zhou Y; Ren X; Zhou F; Zhang J; Huang W; Wang Z; Ding K
Eur J Med Chem; 2024 Apr; 269():116310. PubMed ID: 38479166
[TBL] [Abstract][Full Text] [Related]
12. Effective degradation of EGFR
Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B
Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells.
Brenner D; Brechmann M; Röhling S; Tapernoux M; Mock T; Winter D; Lehmann WD; Kiefer F; Thome M; Krammer PH; Arnold R
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14508-13. PubMed ID: 19706536
[TBL] [Abstract][Full Text] [Related]
14. Discovery of hematopoietic progenitor kinase 1 inhibitors using machine learning-based screening and free energy perturbation.
Feng D; Liu B; Chen Z; Xu J; Geng M; Duan W; Ai J; Zhang H
J Biomol Struct Dyn; 2024 Jan; ():1-13. PubMed ID: 38198294
[TBL] [Abstract][Full Text] [Related]
15. Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress.
Chen H; Guan X; He C; Lu T; Lin X; Liao X
Expert Opin Ther Targets; 2024 Apr; 28(4):237-250. PubMed ID: 38650383
[TBL] [Abstract][Full Text] [Related]
16. Development of a series of quinazoline-2,5-diamine derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors.
Shi H; Tang H; Li Y; Chen D; Liu T; Chen Y; Wang X; Chen L; Wang Y; Xie H; Xiong B
Eur J Med Chem; 2023 Feb; 248():115064. PubMed ID: 36621137
[TBL] [Abstract][Full Text] [Related]
17. Development of decoy oligonucleotide-warheaded chimeric molecules targeting STAT3.
Shih PC; Naganuma M; Tsuji G; Demizu Y; Naito M
Bioorg Med Chem; 2023 Nov; 95():117507. PubMed ID: 37922656
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses.
Shui JW; Boomer JS; Han J; Xu J; Dement GA; Zhou G; Tan TH
Nat Immunol; 2007 Jan; 8(1):84-91. PubMed ID: 17115060
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor.
You D; Hillerman S; Locke G; Chaudhry C; Stromko C; Murtaza A; Fan Y; Koenitzer J; Chen Y; Briceno S; Bhadra R; Duperret E; Gullo-Brown J; Gao C; Zhao D; Feder J; Curtin J; Degnan AP; Kumi G; Wittman M; Johnson BM; Parrish KE; Gokulrangan G; Morrison J; Quigley M; Hunt JT; Salter-Cid L; Lees E; Sanjuan MA; Liu J
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33408094
[TBL] [Abstract][Full Text] [Related]
20. Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation.
Ahn MJ; Kim EH; Choi Y; Chae CH; Kim P; Kim SH
PLoS One; 2024; 19(6):e0305261. PubMed ID: 38923962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
